Baijin Life Science Holdings Ltd
01466
Company Profile
Business description
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
Contact
66 Gloucester Road
Office B, 9/F Pico Tower
Wanchai
Hong Kong
HKGT: +852 36112188
Sector
Consumer Cyclical
Stock type
Cyclical
Industry
Luxury Goods
Fiscal Year End
31 March 2027
Employees
79
Stocks News & Analysis
stocks
Higher fair value for undervalued wide moat share
Investors are overly concerned with upcoming capital expenditures.
stocks
Fears of deteriorating loan quality sends bank share plummeting
We maintain our fair value estimate despite unfavourable economic conditions.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,997.40 | 16.80 | 0.19% |
| CAC 40 | 8,384.87 | 46.74 | -0.55% |
| DAX 40 | 24,671.22 | 323.61 | -1.29% |
| Dow JONES (US) | 51,876.11 | 44.51 | -0.09% |
| FTSE 100 | 10,508.02 | 21.87 | -0.21% |
| HKSE | 23,153.89 | 482.03 | 2.13% |
| NASDAQ | 25,297.62 | 60.99 | -0.24% |
| Nikkei 225 | 68,819.65 | 541.23 | -0.78% |
| NZX 50 Index | 13,553.80 | 58.56 | 0.43% |
| S&P 500 | 7,354.02 | 3.47 | -0.05% |
| S&P/ASX 200 | 8,795.50 | 18.60 | 0.21% |
| SSE Composite Index | 4,034.08 | 6.82 | 0.17% |